Capability profile

Intelligent Factory cell-and-gene-therapy manufacturing

OmniaBio provides process development and GMP manufacturing services for cell and gene therapies while developing automation, robotics, analytics, and digital controls for manufacturing workflows. Planned intelligent-factory capabilities should be separated from currently validated GMP operations.

Add to shortlist Request an introduction

Download profileExplore OmniaBio

Source-bounded strategic technology capability

What it enables

Core features

GMP cell-and-gene-therapy process and manufacturing services
Automation, robotics, and digital manufacturing controls

Defence and security uses

Domestic advanced-therapy manufacturing capacity
Scale-up and technology transfer for cell therapies

Intelligent Factory cell-and-gene-therapy manufacturing

What it enables

Core features

Defence and security uses

What sets it apart

Evidence of maturity

What still needs verification

Continue from the capability to the wider record

Organizations

Mission and ecosystem paths

Take the reviewed record into the conversation ahead.

What it enables

Core features

Defence and security uses

What sets it apart

Evidence of maturity

What still needs verification

Continue from the capability to the wider record

Organizations

Mission and ecosystem paths

Your weekly briefing on Canadian defence

Take the reviewed record into the conversation ahead.